Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Sally C.M. Lau"'
1
Akademický článek
Programmed Cell Death Protein 1 Inhibitors and MET Targeted Therapies in NSCLC With MET Exon 14 Skipping Mutations: Efficacy and Toxicity as Sequential Therapies
Autor: Sally C.M. Lau, MD, MPH, Kirstin Perdrizet, MD, Andrea S. Fung, MD, PhD, Danilo Giffoni M.M. Mata, MD, Jessica Weiss, PhD, Nick Holzapfel, MD, Geoffrey Liu, MD, Penelope A. Bradbury, MD, Frances A. Shepherd, MD, Adrian G. Sacher, MD, MMSc, Harriet Feilotter, MD, Brandon Sheffield, MD, David Hwang, MD, Ming Sound Tsao, MD, Susanna Cheng, MD, Parneet Cheema, MD, Natasha B. Leighl, MD, MMSc
Publikováno v: JTO Clinical and Research Reports, Vol 4, Iss 10, Pp 100562- (2023)
Introduction: NSCLC with MET exon 14 skipping mutation (METex14) is associated with poor outcomes. Integration of novel targeted therapies is challenging because of barriers in testing and drug access. We, therefore, sought to characterize the treatm
Externí odkaz: https://doaj.org/article/1c185004b807431a8e7cb5c371cc5890
Zobrazit plný text záznamu
2
Akademický článek
Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy
Autor: Sally C.M. Lau, MD, MPH, Malcolm Ryan, BSc, Jessica Weiss, PhD, Aline Fusco Fares, MD, Miguel Garcia, MD, Sabine Schmid, MD, Shelley Kuang, MD, Deirdre Kelly, MB BCh BAO, Ming Sound Tsao, MD, Penelope A. Bradbury, MB BCh, Byoung Chun J. Cho, MD, Alexander Sun, MD, Srinivas Raman, MD, Andrew Hope, MD, Meredith Giuliani, MBBS, MEd, PhD, Benjamin H. Lok, MD, PhD, Andrea Bezjak, MD, Geoffrey Liu, MD, MSc, Natasha B. Leighl, MD, MSc, Frances A. Shepherd, MD, Adrian G. Sacher, MD, MMSc
Publikováno v: JTO Clinical and Research Reports, Vol 2, Iss 12, Pp 100251- (2021)
Introduction: The addition of durvalumab after chemoradiation therapy (CRT) in unresectable stage III NSCLC significantly improves survival. The benefit of this approach in elderly patients is controversial given the toxicity associated with CRT and,
Externí odkaz: https://doaj.org/article/eafc28dbd2bc49cd99b777e1bd11e394
Zobrazit plný text záznamu
6
Spotlight on Small-Cell Lung Cancer and Other Lung Neuroendocrine Neoplasms
Autor: Lynnette Fernandez-Cuesta, Alexandra Sexton-Oates, Leyla Bayat, Matthieu Foll, Sally C.M. Lau, Ticiana Leal
Publikováno v: American Society of Clinical Oncology Educational Book.
Lung neuroendocrine neoplasms (NENs) encompass a spectrum of neoplasms that are subdivided into the well-differentiated neuroendocrine tumors comprising the low- and intermediate-grade typical and atypical carcinoids, respectively, and the poorly dif
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::817280661e931053d0e3f4ba97c4887f
https://doi.org/10.1200/edbk_390794
Zobrazit plný text záznamu
7
Squamous cell lung cancer: Current landscape and future therapeutic options
Autor: Sally C.M. Lau, Yuanwang Pan, Vamsidhar Velcheti, Kwok Kin Wong
Publikováno v: Cancer cell. 40(11)
Squamous cell lung cancers (lung squamous cell carcinomas [LUSCs]) are associated with high mortality and a lack of therapies specific to this disease. Although recurrent molecular aberrations are present in LUSCs, efforts to develop targeted therapi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a1086c249defcb3f24e0f8df93936b0
https://pubmed.ncbi.nlm.nih.gov/36270277
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje